Treatment of acidosis in CKD.

M. Yaqoob
DOI: https://doi.org/10.2215/CJN.00240113
2013-03-07
Abstract:Metabolic acidosis (MA) in advanced CKD results from a progressive reduction in the capacity of the kidneys to generate sufficient ammonia to excrete the daily production of hydrogen ions (equivalent to approximately 1 mmol/kg body weight) leading to the formation of a new steady state at the cost of a reduction in blood pH. MA is a relatively common complication in patients with advanced CKD, particularly when GFR falls below 30 ml/min (1). MA adversely affects protein and muscle metabolism and bone turnover, compounding the mineral-bone disorder of uremia. In addition, MA is also associated with increased inflammatory mediators, insulin resistance, and corticosteroid and parathyroid hormone production. This may
What problem does this paper attempt to address?